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Cytolysin-Mediated Translocation (CMT):
A Functional Equivalent of Type III Secretion
in Gram-Positive Bacteria
damental difference in cellular architecture between
Gram-negative and Gram-positive bacteria, the latter of
which lacks the outer membrane that serves as a barrier
to secretion. The type III system functions both as a
specialized pathway for secretion across the outer
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membrane and for translocation of the secreted ef-
fectors across the host cell cytoplasmic membraneSummary
(Hueck, 1998; Cheng and Schneewind, 2000). Since
Gram-positive bacteria lack an outer membrane, it isType III secretion for injection of effector proteins into
likely that they require only a translocation apparatushost cells has not been described for Gram-positive
for injection of proteins that have been secreted frombacteria despite their importance in disease. Here, we
the bacterium via the general secretory pathway.describe an injection pathway for the Gram-positive
Gram-positive pathogens typically secrete multiplepathogen Streptococcus pyogenes that utilizes strep-
proteins into their environments. For example, Strepto-tolysin O (SLO), a cholesterol-dependent cytolysin.
coccus pyogenes (the group A streptococcus) is knownThe data support a model in which an effector is trans-
to secrete upwards of 20 distinct polypeptides (Alouf,located through the SLO pore by a polarized process.
1980). This organism is the causative agent of numerousThe effector, SPN (S. pyogenes NAD-glycohydrolase),
suppurative infections of the pharynx (e.g., “strepis capable of producing the potent second messenger
throat”) and soft tissues (impetigo and necrotizing fasci-cyclic ADP-ribose, and SLO and SPN act synergisti-
itis), as well as several systemic diseases that can resultcally to trigger cytotoxicity. These data provide a novel
from toxigenic (scarlet fever and toxic shock–like syn-paradigm for the function of the cholesterol-depen-
drome) or immunopathological (rheumatic fever) proc-dent cytolysin family and its wide distribution suggests
esses (Bisno and Stevens, 1996). While many of thethat cytolysin-mediated translocation (CMT) may be
proteins secreted by S. pyogenes, including superanti-the equivalent of type III secretion for Gram-positive
gens, proteases, and hemolysins, have readily identifi-pathogens.
able activities, the mechanisms by which many of these
proteins contribute to the development of disease are
Introduction not clearly understood.
Since the skin is one of the primary tissues that S.
The recognition that pathogenic bacteria translocate pyogenes can infect, our previous studies examined the
proteins from the bacterial cytoplasm directly into the interaction of S. pyogenes with human keratinocytes
host cytosol is one of the most exciting advances in and demonstrated that mutants defective in production
our understanding of the interplay between microbial of the hemolysin streptolysin O (SLO) lost the ability to
pathogens and their hosts. The injected proteins are manipulate several keratinocyte proinflammatory sig-
often similar in structure and function to eukaryotic sig- naling pathways (Wang et al., 1997; Ruiz et al., 1998).
nal transduction factors and modify the flow of informa- This was of interest, since in addition to interacting with
tion through a given signal transduction pathway. Muta- signaling pathways, SLO has other characteristics that
tions that prevent a bacterium from injecting effectors suggest that it could function as a translocation appa-
typically render the microorganism avirulent (Hueck, ratus.
1998; Galan and Collmer, 1999; for review, see Cheng First and foremost, SLO is a member of an expansive
and Schneewind, 2000). family of highly conserved pore-forming cytolysins.
While the process of injection is emerging as a general Known as the cholesterol-dependent cytolysins (CDCs)
virulence mechanism for both animal and plant patho- (formerly called the thiol-activated cytolysins) (Tweten,
gens, it has been exclusively described among Gram- 1995), members share 40%–70% homology and are se-
negative bacterial species. It has not been observed for creted from the bacterium as water-soluble monomers
Gram-positive bacteria, despite the fact that this group that bind cholesterol in the target cell membrane (Bil-
of organisms contains a large number of species that lington et al., 2000). There, they form large homo-oligo-
are highly pathogenic for humans, animals, and insects. meric complexes (Rossjohn et al., 1997) that may
The proteins that comprise the injection machinery, contain up to 50 individual monomers. The resulting
known as the type III secretory pathway, are highly con- transmembrane pore can be up to 30 nm in diameter
served among Gram-negative bacteria (Hueck, 1998). (Sekiya et al., 1993; Shatursky et al., 1999) and provides
However, examination of the multiple genome se- the toxins with their well characterized hemolytic and
cytolytic properties. In the case of Listeria monocyto-quences that have been derived for numerous Gram-
genes, the expression of a CDC (listeriolysin O) is essen-positive pathogens has yet to reveal the presence of
tial for virulence and is required for the ability of thethese genes. This may not be surprising, given the fun-
organism to escape from a membrane-bound vacuole
into the cytosol following invasion into the host cell* To whom correspondence should be addressed (e-mail: caparon@
(Cossart et al., 1989). However, the other Gram-positiveborcim.wustl.edu).
bacteria that express toxins of this family, including S.† Present address: Molecular Biology Department, Princeton Univer-
sity, Princeton, NJ 08544. pyogenes, are predominantly extracellular pathogens,
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Figure 1. A 52 kDa Streptococcal Protein Is
Present in a Triton X-100-Soluble Cellular
Fraction of Infected Keratinocytes
Following infection by the indicated S. pyo-
genes strains, HaCaT keratinocytes were
washed, treated with Triton X-100, and the
soluble and insoluble fractions analyzed in a
Western blot using a commercial anti-SLO
antiserum. SLO is indicated by the arrow at
the left of the figure. Migration of several mo-
lecular size standards is indicated at the right
of the figure.
and while CDC mutants usually show diminished viru- insoluble fraction may contain some bacteria, these data
suggest that SLO predominantly targets the detergent-lence, the function of any CDC besides listeriolysin O
during infection has not been clearly established (El- insoluble, cholesterol-rich microdomain regions of the
cellular membrane. Insertion of SLO into this fractionlemor et al., 1999; Jost et al., 1999).
The large pore size of the CDCs would be ideal for required adherence, since it was not detected following
infection with a SLO-producing but adhesin-deficienttranslocation of effectors from Gram-positive bacteria,
which would likely be exported via the general secretory mutant (JRS145, Figure 1) (Ruiz et al., 1998) and as
expected, was not detected after infection with a SLO-pathway and be in a fully folded conformation. In fact,
SLO pores are large enough that SLO is routinely used deficient mutant (SLO6, Figure 1) or in uninfected cul-
tures (Figure 1). A surprising result was the presence offor the controlled permeabilization of cells in culture to
translocate large heterologous proteins into intracellular an approximately 52 kDa protein that was detected only
in the Triton X-100 soluble fraction (JRS4, Figure 1).compartments, including restriction endonucleases and
immunoglobulins (Bhakdi et al., 1993). The ease with The presence of this band in this fraction also required
adherence and the pore-forming SLO since it was miss-which SLO can be used for controlled translocation in
vitro suggests the possibility of a similar function in ing following infection with the respective mutants
(JRS145, SLO6, Figure 1). It was also missing from unin-vivo, acting as a translocation apparatus for injection of
streptococcal effector proteins into the host cell cytosol. fected cells, suggesting that it was of streptococcal
origin.In this report, we show that a molecule of streptococ-
cal origin with eukaryotic signal transduction properties
is translocated into the keratinocyte cytosol in a SLO- Cytolysin-Mediated Translocation
dependent manner. The high degree of conservation of The anti-SLO antiserum recognized bands correspond-
CDCs among diverse species of Gram-positive patho- ing in size to SLO and to a 52 kDa band in supernatant
gens suggests that cytolysin-mediated translocation from JRS4 streptococci cultured in the absence of
(CMT) may be a general mechanism for injection of ef- HaCaT cells (Figure 2). Neither band was present in
fectors and thus, serve as the functional equivalent of culture medium alone (data not shown) confirming that
type III secretion systems for Gram-positive pathogens. the 52 kDa band is a secreted product of streptococcal
These data provide a novel function for this large family origin. Analysis of several mutants demonstrated that
of cytolysins and suggest a new paradigm for analysis the 52 kDa protein cross-reacts with the antiserum and
of secreted virulence factors with consideration that was not a processed form of SLO (see below). Taken
they may function not only in extracellular environments, together, these data suggest that the 52 kDa protein is
but also potentially within intracellular compartments. secreted from the streptococcus and introduced into
the HaCaT cytosol by a process that requires SLO. How-
ever, in addition to cytosol, the Triton X-100 solubleResults
fractions contain some membrane components and
possibly some components of the streptococcus. Thus,An Unexpected 52 kDa Band
Previous studies indicated that for S. pyogenes strain to better define the localization of the 52 kDa band, an
alternative fractionation procedure was used to produceJRS4, SLO’s ability to manipulate keratinocyte signaling
responses was dependent on expression of the JRS4 a highly specific target cell cytosolic fraction. This frac-
tionation method was developed for the analysis ofadhesin for keratinocytes (the M protein) and on de novo
protein synthesis following adherence (Ruiz et al., 1998). translocation of microbial proteins via type III secretion.
The method uses a cholesterol-dependent detergentTo probe the basis of these phenomena, we obtained
an anti-SLO antiserum (see Experimental Procedures) that permeablizes cells but cannot permeablize the cho-
lesterol-free membrane of bacteria, (Bomford, 1980; Leeand analyzed the distribution of SLO during infection of
HaCaT keratinocytes. Fractionation of the HaCaT cells and Schneewind, 1999) and does not efficiently solublize
components of the cellular membrane. Analysis of cyto-with Triton X-100 revealed that all detectable protein
corresponding to the size of mature SLO was present sol from infected HaCaT cells prepared by this method
revealed the presence of the 52 kDa band (JRS4, Figurein the insoluble, but not the soluble fraction (compare
JRS4 Insoluble to JRS4 Soluble, Figure 1). While the 2). The presence of the band in this cytosolic fraction
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published data; see Figure 3A). An additional mutant
was constructed that contains a nonpolar in-frame dele-
tion in spn (Figure 3A). This mutant (SPN1) does not
produce the 52 kDa protein recognized by the antiserum
and secretes no detectable NAD glycohydrolase activ-
ity, but does secrete SLO at levels equivalent to wild-
type (Figure 3B) (Ruiz et al., 1998). In contrast, mutant
SLO1 contains an insertional inactivation of the gene
encoding SLO, expresses no detectable SLO protein or
SLO-dependent hemolytic activity, but does express the
52 kDa protein and unaltered levels of NAD glycohydro-
lase activity (Figure 3B). Both mutants do not differ from
wild-type JRS4 in their abilities to adhere to keratino-
cytes (Figure 3B).
The Translocated 52 kDa Protein Is SPN
In order to assess whether translocation was specific
for keratinocytes, the abilities of the various mutants
to translocate the 52 kDa protein into A549 cells was
analyzed. This human alveolar carcinoma cell line hasFigure 2. The 52 kDa Protein Is Translocated into the Cytoplasm of
frequently been used for investigations of streptococ-Infected Keratinocytes in a SLO-Dependent Manner
cal–host cell interactions (Tsai et al., 1998) and it wasA Western blot analysis of JRS4 culture supernatant using an anti-
SLO antiserum is shown on the left. The right of the figure shows also possible to prepare cytosol from A549 cells using
a Western blot analysis of cytoplasmic fractions prepared from in- an alternative and nondetergent-based method for lysis
fected HaCaT keratinocytes that were lysed with a detergent that (sonication, see Experimental Procedures) to ensure
does not lyse the bacteria (see Experimental Procedures). Migration that the appearance of SPN in the cytosolic fraction
of SLO and several molecular size standards are indicated to the
was not the result of solubilization from the membrane.left and right of the figure, respectively.
Similar to keratinocytes, infection by JRS4 resulted in
the presence of the 52 kDa protein in the cytosolic frac-
tion (Figure 4), and its appearance required SLO (seealso required expression of SLO since it was missing
below). The band was not present following infectionin samples prepared from infection by a SLO-deficient
with the SPN-deficient mutant SPN1 (Figure 4), demon-mutant (SLO1, Figure 2).
strating that the cytosolic 52 kDa band is not of host
cell origin, but is the streptococcal NAD-glycohydrolase.The 52 kDa Protein Has Eukaryotic Signal
One possible explanation for the cytosolic location ofTransduction Properties
SPN is that the host cells are simply becoming highlyDetermination of the N-terminal amino acid sequence
porated by SLO such that it is impossible to distinguishof the 52 kDa band generated a 14 amino acid sequence
intra- from extracellular contents. Alternatively, SPNthat was nearly identical to an experimentally derived
may interact with a cellular receptor whose internaliza-N-terminal amino acid sequence of the mature secreted
tion and subsequent release into the cytosol is promotedform of Group C streptococcal NAD-glycohydrolase
by a signaling event triggered by the interaction of SLO(Gerlach et al., 1996). This molecule has the ability to
with the cellular membrane. In both scenarios, it wouldcleave NAD into free nicotinamide and ADP-ribose and
be expected that localization would only require theit has long been known that S. pyogenes also secretes
presence of SLO and SPN, and that separate bacteriala protein with this activity (Carlson et al., 1957). More
cells could provide these. However, coinfection withrecently, it has been shown that the S. pyogenes NAD-
both mutants could not appreciably rescue the transportglycohydrolase can synthesize cyclic ADP-ribose (Kara-
of SPN into the cytosol, even when the infections weresawa et al., 1995), a potent second messenger in several
conducted at high multiplicity (SPN1 1 SLO1, Figure 4).eukaryotic signal transduction pathways (Guse et al.,
Thus, these data suggest that SPN enters the cytosol1999; Cancela et al., 2000). Examination of the available
through the SLO pore and that the streptococcal cellS. pyogenes genome information (http://www.genome.
must carefully coordinate the process of translocation.ou.edu/strep.html) revealed a single open reading frame
that contained an almost identical match to the N-termi-
nal sequence of the 52 kDa band. The region of identity SPN Is Active in the Cytosol
While NAD glycohydrolase activity was undetectable inwas preceded by a stretch of 37 amino acid residues
characteristic of a prokaryotic signal sequence. This uninfected cells (Figures 5A and 5B), it was possible
to detect high levels of NAD glycohydrolase activity inopen reading frame was provisionally designated spn
(S. pyogenes NAD-glycohydrolase). Remarkably, spn is cytosol from HaCaT (Figure 5A) and A459 (Figure 5B)
cells infected with wild-type strain JRS4. This NADlocated adjacent to the gene that encodes SLO in the
streptococcal genome (Figure 3A). Insertional inac- glycohydrolase activity was the result of the SLO-depen-
dent translocation of SPN, as demonstrated by the fail-tivation of spn also abolished expression of SLO (C.
Easter and M. C., unpublished data) suggesting that ure to detect activity following infection with the SPN-
deficient mutant (SPN1, Figure 5A) and the very low toboth genes are cotranscribed from a promoter that is
located just upstream of spn (C. Easter and M. C., un- undetectable levels observed upon infection with the
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Figure 3. The 52 kDa Band Is the Streptococ-
cal NAD-glycohydrolase (SPN) and Its Gene
Is Adjacent to SLO in the Streptococcal Chro-
mosome
(A) The N-terminal amino acid sequence de-
rived for the 52 kDa band corresponded to a
single open reading frame highly homologous
to the NAD-glycohydrolase of group C strep-
tococci. Designated spn (for S. pyogenes
NAD-glycohydrolase), the open reading frame
is located adjacent to the gene that encodes
SLO (slo). Mutational data (not shown) sug-
gest that spn and slo are cotranscribed (indi-
cated by the broken line and arrow under the
figure) from a promoter located upstream of
spn (indicated by the “p”). The region of spn
removed to construct the nonpolar deletion
mutation in SPN1 that does not affect expres-
sion of SLO is indicated by the striped box,
and the specific amino acid residues that
were removed are indicated above the arrow
depicting the open reading frame. Other open
reading frames are indicated by the open
arrows and the information located under the
arrows presents the gene most similar based
on comparison to the database. Arrows la-
beled “orf” were not similar to any gene in
the database.
(B) A Western blot analysis of culture super-
natant from wild-type JRS4 and isogenic mutants defective in SLO (SLO1) and SPN (SPN1) is shown. Labeled arrows at the left indicate the
migration of SLO and SPN, and the migration of several molecular size standards is shown on the right of the figure. Analysis of relevant
phenotypes is indicated beneath each strain, including glycohydrolase activity (“SPN”), SLO-specific hemolytic titer (“SLO”), and ability to
adhere to HaCaT keratinocytes (“Adherence”). Adherence is shown as the percent of bacteria bound to cells after a 3.75 hr infection.
SLO-deficient mutant (SLO1; Figures 5A and 5B). Trans- Translocation Has Characteristics
of a Polarized Processlocation was a coordinated process since coinfection
Taken together, the data support a model in which bac-with the mutants also did not result in translocation of
teria adherent to the cell membrane inject SPN throughNAD glycohydrolase activity (SLO1 1 SPN1, Figure 5A).
the SLO pore into the cytosol. The inability of a coinfec-Furthermore, coordinated translocation required bacte-
rial adherence since infection with the keratinocyte-
adhesin defective strain JRS145, which secretes equiva-
lent amounts of SPN and SLO to wild-type JRS4 (Ruiz
et al. 1998 and data not shown), generated no detectable
activity in HaCaT cells (Figure 5A). The high levels of
activity observed in JRS145 infected A549 cells (Figure
5B) can be explained by the fact that streptococci pos-
sess multiple adhesins for A549 cells and JRS145 can
still adhere to these cells (data not shown), which further
demonstrates that adhesion is necessary for transloca-
tion. A role for alterations of the target cell cytoskeleton
was evaluated by conducting infections in the presence
of the microfilament inhibitor cytochalasin D. However,
this treatment had essentially no effect on the appear-
ance of NAD glycohydrolase activity in host cell cytosol
following infection by the wild-type strain (JRS4 1
CytoD; Figures 5A and 5B). Because endocytosis and
streptococcal invasion are cellular-driven processes
that require microfilament reorganization (Greco et al.,
Figure 4. The 52 kDa Translocated Protein Is SPN
1995; Tsai et al., 1998), these data indicate that the
A Western blot analysis of cytoplasm prepared from A549 cells
appearance of SPN activity in the cytosol results from infected by the indicated strains is shown. Cytoplasm was prepared
neither endocytosis of SPN nor bacterial invasion of following lysis of the infected cells by sonication. The 52 kDa protein
reacting with the antiserum was present in the cytoplasmic fractionthe target cell. The NAD glycohydrolase activity was
following infection by the wild type (JRS4), but not the SPN-deficientdependent on SLO and was not due to induction of an
mutant (SPN1). The band was not detected following a mixed infec-endogenous cellular NAD-glycohydrolase by cytocha-
tion by SLO- and SPN-deficient mutants (SLO1 1 SPN1) and in
lasin D, since infection by the SLO-deficient mutant in uninfected A549 cells. The arrow at the left of the figure indicates
the presence of cytochalasin D resulted in no detectable the migration of SPN, and the migration of several molecular size
standards is shown on the right.activity (SLO1 1 CytoD, Figure 5B).
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tion of mutants SLO1 and SPN1 to rescue SPN translo-
cation suggests that SPN translocation is not a stochas-
tic process; rather, it appears to be coordinated. To
investigate this in greater detail, the distribution of SPN
activity during infection was analyzed. Approximately
equivalent total activities were recovered following in-
fection with the wild type and SLO-deficient mutants
(compare JRS4 to SLO1, Figure 5C). However, the distri-
bution of activity differed markedly. For the wild-type
bacterium, 71% of the total recovered activity was di-
rected into the cytosol and less than 25% was found in
the cell-free culture supernatant (JRS4, Figure 5C). This
indicates that a majority of the secreted SPN is targeted
for translocation. In contrast, nearly all of the activity
recovered from infection with the SLO-deficient mutant
was found in the culture supernatant (SLO1, Figure 5C).
As expected, no SPN activity was detected in any com-
partment during infection with the SPN-deficient mutant
or in uninfected cultures (Figure 5C). These results sug-
gest that the secretion and translocation of SPN has
characteristics of a polarized process in the presence
of SLO, where SPN is directed into the target cell.
SPN Is Required for the SLO-Dependent
Modulation of Membrane Function
Streptococci secrete multiple products that can be toxic
to cells including a protease (Lukomski et al., 1999) and
a second potent cytolysin, streptolysin S (Alouf, 1980;
Betschel et al., 1998). However, JRS4 rapidly damages
the membranes of keratinocytes by a mechanism that
requires SLO (Ruiz et al., 1998). This effect is readily
observed as the appearance of nuclear staining by the
normally membrane-excluded fluorescent probe ethid-
ium homodimer-1 (EthH-1) and the loss of staining by
intracellular esterase-activated probe Calcein AM. Typi-
cally, HaCaT cells infected with JRS4 appear normal at
2 hr after infection, but by 3 hr, about 35% of the cells
have lost the ability to exclude EthH-1(the panel for JRS4
in Figure 6A shows a micrograph of a typical field at 3
hr. Quantitative data are presented in Figure 6B). By
5 hr, virtually all the cells exhibit evidence of having
compromised membranes (JRS4, Figures 6A and 6B)
and by 7 hr, few cells remain adherent (Figure 6A). For
Figure 5. Translocation of SPN Is Coordinated and Once Translo-
comparison, at a time in which most cells infected withcated, SPN Is Enzymatically Active in Host Cell Cytosol
JRS4 show evidence of having damaged membranes,
Following infection by the indicated strains, NAD glycohydrolase
only about 10% of cells infected by SLO mutants demon-activity was measured in cytoplasm prepared from (A) HaCaT cells
strate this effect (SLO1, Figure 6A, see also Ruiz et al.,and (B) A549 cells. (C) The distribution of NAD glycohydrolase activ-
1998) and at 7 hr, most cells are still adherent (SLO1,ity between culture supernatant, the bacteria and the host cell cyto-
plasm was determined for each of the indicated strains following Figure 6A). While these data indicate that SLO is re-
infection of HaCaT cells. The height of each bar indicates the total quired, analysis of the SPN-deficient mutant indicates
amount of activity measured and the numbers within the sections that SLO is not sufficient for this response. At all time
of each bar indicate the percentage of total activity that is associated points, infection by the SPN mutant resembled infectionwith each specific fraction. Cytoplasm was prepared from HaCaT
by the SLO-deficient mutant both in terms of numbercells as described for Figure 2 and from A549 as described for
of cells with damaged membranes (compare SLO1 andFigure 4. The amount of activity associated with the bacteria was
SPN1; Figures 6A and 6B) and the appearance and num-determined by pseudoinfection as described in the Experimental
Procedures. Strains analyzed included the wild-type strain (JRS4), ber of cells that remained adherent (Figure 6A). Because
an SPN-deficient mutant (SPN1), a SLO-deficient mutant (SLO1), the SPN-deficient mutant produces SLO, the manipula-
and mixed infection of SLO and SPN mutants (SLO1 1 SPN1). Mu- tion of membrane function cannot solely be due to an
tant JRS145 lacks the adhesin that allows it to bind to HaCaT kera-
effect of the cytolysin, but must also involve SPN. Thetinocytes. However, it retains the capacity to adhere to A549 cells.
observation that the SLO-deficient mutant still producesAs indicated, certain infections were conducted in the presence of
SPN, but is reduced in its ability to damage membranes,cytochalasin D (1 CytoD). An asterisk indicates that activity was
suggests that SPN must reside in a cytosolic compart-below the limit of detection of the assay (# 8000 pmol NAD cleaved
min21 mg21. The data represent the mean 6 standard error where ment in order to contribute to this effect. Thus, these
indicated of at least two independent infections, each of which was data are consistent with a model in which SLO is re-
analyzed at least in duplicate. quired for the translocation of SPN into the cytosol.
Cell
148
Figure 6. SPN–SLO Synergism in a Cytotoxic
Response
HaCaT keratinocytes were infected with the
wild-type strain (JRS4), a SLO-deficient mu-
tant (SLO1), and an SPN-defective mutant
(SPN1). At the indicated times, samples were
removed and stained with the fluorescent
probes calcein AM and EthH-1 and examined
under a fluorescent microscope. Viable kera-
tinocytes stain with calcein AM and appear
green, while the nuclei of keratinocytes
whose membrane function has become com-
promised stain with EthH-1 and appear red.
(A) Fluorescent micrographs of stained
HaCaT cells infected with JRS4, SLO1, and
SPN1 for the indicated times.
(B) Quantitative assessment of the percent of
keratinocytes stained with ethidium homodi-
mer-1. An asterisk indicates that no cells were
stained with the EthH-1 in any microscopic
fields examined. Data represent the aver-
age 6 standard error derived from examina-
tion of at least 5 randomly chosen micro-
scopic fields.
Discussion lar species (Galan and Collmer, 1999). This would be
consistent with CMT in that there are relatively few re-
ports of NAD-glycohydrolases among CDC producingIn this study, we have shown that the CDC of the Gram-
positive pathogen S. pyogenes directs the translocation bacteria, and examination of the database did not reveal
any other protein with significant homology to SPN.of a streptococcal effector molecule into the host cell
cytosol. Furthermore, the effector, which is capable of Both CMT and type III secretion have distinct secre-
tion and translocation stages. In type III systems, ef-producing the potent eukaryotic second messenger
molecule cyclic ADP-ribose, contributes to a cytotoxic fectors are thought to be secreted down the hollow
conduit of a needle-like export apparatus that resemblesresponse by keratinocytes to infection by S. pyogenes.
The high degree of conservation of CDCs among diverse the flagellar basal body (Harshey and Toguchi, 1996;
Hueck, 1998). Effectors pass from the bacterial cyto-species of Gram-positive pathogens suggests that cyto-
lysin-mediated translocation (CMT) is a widespread plasm, cross the inner and outer membranes of the
Gram-negative cell, and may transit in a significantlyphenomena and may be the functional equivalent of
type III secretion for Gram-positive bacteria. folded state. The proteins are not processed during se-
cretion and the recognition signal for secretion may re-There are many similarities between CMT and type III
secretion. The type III systems are typically identified side in the amino-terminal sequence of the polypeptide
(Miao and Miller, 2000) or within the 59 region of thebased on the high degree of conservation of the secre-
tion–translocation apparatus between different species mRNA (Cheng and Schneewind, 2000). In contrast, CMT
can utilize a protein that is exported via the general(Hueck, 1998). For CMT, the CDC family includes at
least 18 distinct but highly related members such as secretory pathway. As is typical of secreted Gram-posi-
tive proteins, SPN has a signal sequence, is likely se-perfringolysin O, alveolysin O, streptolysin O, and listeri-
olysin O. (Tweten, 1995; Billington et al., 2000). In type creted in an unfolded state, the signal sequence re-
moved and the polypeptide released to fold in theIII secretion systems, it is well established that the trans-
located effectors are relatively poorly conserved in both extracellular milieu (Nagarajan, 1993). These differences
likely reflect the fact that Gram-positive bacteria lackstructure and function and are often unique for a particu-
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the outer membrane that is a barrier to secretion in
Gram-negative bacteria.
Under certain conditions in vitro, the effectors of both
type III secretion (Cornelis and Wolf-Watz, 1997) and
CMT can be secreted into the extracellular medium.
However, when in contact with a host cell, the predomi-
nant fate of the effectors is to be translocated across
the host cell membrane. This process is not well under-
stood for type III secretion. The protein conduit may
extend across the host cell membrane to form a continu-
ous channel between the bacterial and host cell cyto-
sols. However, an alternative model suggests that sev-
eral proteins that are secreted via the type III pathway
insert into the host cell membrane to form a transloca-
tion apparatus (Hakansson et al., 1993; Neyt and Cor-
nelis, 1999; Tardy et al., 1999). Furthermore, in Yersinia
enterocolitica, the translocation apparatus has been
shown to form a transmembrane pore that shares many
characteristics with SLO (Neyt and Cornelis, 1999).
For CMT, it is likely that pore formation is important for
the translocation stage. However, several observations
suggest that translocation is not simply the result of
diffusion of effectors through the pore. These include
the observation that translocation is contact dependent,
that a mixed infection of SLO and SPN mutants does
not rescue translocation, and that the majority of the
secreted SPN is translocated. This may imply that there
is a protected channel formed between the bacterium
and the translocation apparatus, similar to type III secre-
tion. Alternatively, this may indicate protein–protein rec-
ognition between effector and translocator. A similar Figure 7. A Model for CMT with Comparisons to Translocation Path-
question concerning targeting for extracellular secretion ways of Gram-Negative Bacteria and Eukaryotic Cells
versus translocation is a subject of considerable investi- Directed translocation of effector molecules to manipulate the be-
gation in type III pathways (for review, see Cheng and havior of their target cells is a mechanism shared by Gram-positive
bacteria (via CMT), Gram-negative bacteria (via type III secretion),Schneewind, 2000). As with type III secretion systems,
and cytotoxic lymphocytes (via Granule exocytosis). The three path-the development of reagents for confocal microscopy
ways share many similarities. All are contact dependent and initiateand a CMT-specific reporter assay will be important
with specific recognition of a cellular receptor (“R”) by an adhesiveto provide additional evidence for the translocation of
molecule (“A”) of the effector-producing cells. The process of injec-
effectors and will be useful for dissection of the molecu- tion has distinct export and translocation stages. For type III secre-
lar mechanisms of translocation. tion, effectors are secreted across the bacterial cell membrane
Pore-mediated translocation may be a pathway that (“bcm”), periplasm, and bacterial outer membrane (“bom”) by the
flagella-like type III secretion channel. In Yersinia enterocolitica,is also utilized by eukaryotic cells. The molecule perforin
several proteins exported from the secretion channel interact towas identified as essential for the granule exocytosis
form a transmembrane pore (“translocation pore”) that then directspathway used by cytotoxic lymphocytes to kill target
translocation of effectors into the host cell cytosol. For CMT, effectorcells (Shresta et al., 1998). However, it is not sufficient
molecules are exported across the bacterial cellular membrane and
to cause apoptosis in target cells. Instead, it mediates cell wall (“cm”) via the generalized secretion pathway (“Sec secre-
the entry of granzymes, proteases secreted by the cyto- tion pathway”) and translocated into the target cell using a CDC.
toxic lymphocyte, into the cytoplasm of infected cells. For cytotoxic lymphocytes, exocytosis of granules exports perforin
and granzymes across the cellular membrane (“cm”). One modelOne model proposes that granzymes are translocated
proposes that granzymes are translocated into the target cell via athrough a perforin pore formed in the target cell by
pore formed by perforin. Following injection, the function of all threeoligomerized perforin by a mechanism that is analogous
pathways is to manipulate signaling pathways of the target cell.to CMT (Figure 7) (Shresta et al., 1998).
Despite the evidence for perforin–granzyme syner-
gism, it has rarely been considered that the secreted
nism of cytotoxicity is unknown, our preliminary dataproducts of Gram-positive bacteria may act synergisti-
suggest that HaCaT keratinocytes that have been sub-cally. In the case of exported products with enzymatic
jected to multiple passages in vitro no longer demon-activity, it has generally been assumed that they function
strate the cytotoxic response, despite the fact that ac-exclusively in an extracellular compartment. Based on
tive SPN is still translocated during infection. These datathis, it has been difficult to understand the possible
and the rapid time course of the response suggest thatfunctions of SPN. Our observation that SPN is translo-
cytotoxicity is not simply the result of depletion of NAD.cated via CMT and functions in the intracellular compart-
Furthermore, cells like erythrocytes are incapable ofment provides a new perspective on SPN function. Fur-
healing pores and are lysed by SLO alone. However,thermore, translocated SPN is required for triggering a
cytotoxic response in infected cells. Though the mecha- nucleated cells have a capacity to heal SLO pores. Thus,
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as follows: Oligonucleotide primers KpnSLO (TCAGTG ATAGGT ACSPN may interact with a host cell signaling pathway that
CTAT CCAGCA) and 3SLO2 (CCAGTC CCGGGT ATAAGT AATC)modulates the ability of the cell to repair damage caused
were used to amplify a fragment from JRS4 chromosomal DNA thatby SLO or other streptococcal products. Consistent with
contained a 1216 bp fragment that overlapped the 39 end of slo by
this idea is the observation that the translocator, SLO, 8 bp, which was then cloned by a TA-tail method using a commerical
seems to target the cholesterol-rich microdomains of vector (pCR2.1, Invitrogen). The slo region was removed from the
resulting plasmid (pSLO5) and inserted into the integrative plasmidthe cell membrane, which provide a nexus for organizing
pCIV2 (Okada et al., 1993) using KpnI (site italicized above) and XbaImolecules involved in signal transduction, including
(site derived from pCR2.1) to create pSLO7. Integration of pSLO7GPI-anchored proteins and tyrosine kinases (Harder and
into the JRS4 chromosome creates a control strain (SLO5) thatSimons, 1997).
contains a functional copy of slo followed immediately by a polar
Other than in Listeria (Cossart et al., 1989), very little is insertion. The chromosomal structure of SLO5 was confirmed by
understood about the function of CDCs in pathogenesis. PCR using appropriate primers. This strain was translocation com-
petent, ensuring that insertional inactivation of slo in SLO1 did notThe data in this paper have provided a novel paradigm
have any adverse effects on transcription of an adjacent gene neces-for this family of pore-forming molecules with important
sary for translocation.implications for analysis of the functions of virulence
factors secreted from Gram-positive pathogens.
Infection of Cultured Cells
The HaCaT human keratinocyte cell line (Boukamp et al., 1988)Experimental Procedures
was cultured and infected with the various S. pyogenes strains as
described previously (Wang et al., 1997) using bacteria resuspendedBacterial Strains and Culture Conditions
to a final OD600 5 0.033 in prewarmed medium and using 15 ml ofThe S. pyogenes strains JRS145 (Caparon et al., 1992), SLO1, and
the suspension to infect cells in a 75 cm2 flask. Cultures of A549SLO6 (Ruiz et al., 1998) were derived from JRS4 (Scott et al., 1986).
cells (ATCC CCL-185), utilized A549 medium (Dulbecco’s modifiedThe host for molecular cloning experiments was Escherichia coli
Eagle’s medium, supplemented with glucose, 4500 mg/ml; L-gluta-DH5a (Life Technologies, Inc.). Luria-Bertaini (LB) medium was used
mine, 0.584 mg/ml; HEPES, 50 mM; fetal bovine serum 10%; andfor culture of E. coli, and S. pyogenes strains were grown in Todd-
nonessential amino acids, 1%). Infection of A459 cells was con-Hewitt medium (BBL) supplemented with 0.2% yeast extract (Difco)
ducted identically to infection of HaCaT cells. The adherence pheno-(THY medium). When appropriate, antibiotics were added to the
types of various S. pyogenes strains were routinely confirmed bymedium at the following concentrations: kanamycin, 500 mg/ml for
microscopy (Wang et al., 1997) or by determination of the numberS. pyogenes; erythromycin, 1 mg/ml for S. pyogenes and 750 mg/ml
of colony forming units that remained associated with the cell mono-for E. coli; and ampicillin, 50 mg/ml for E. coli. Because all mutations
layers following several washes. When indicated, cytochalasin Dwere stable, growth of the various S. pyogenes strains for infection
was added 30 min prior to infection at 0.1 mg/ml in HaCaT infectionsof eukaryotic cells did not routinely include antibiotics.
and 0.2 mg/ml in A549 infections, which were the highest concentra-
tions that did not alter visible cell morphology by 5.5 hr. CytochalasinConstruction of an SPN-Deficient Mutant
D has been shown to block bacterial entry into eukaryotic cells atThe oligonucleotide primers SpnXho1 (GCACCT TATACA TACTCG
these concentrations (LaPenta et al., 1994; Martinez et al., 2000).AGCTTC CTATCT TGC) and SpnNco1 (GCTTTG GCTGGA GCCATG
GGTAGC AGTTTA TTAGC) were used to amplify the entire spn open
Preparation and Analysis of Triton X-100 Cell Fractionsreading frame from JRS4 chromosomal DNA. The resulting PCR
Following 4 hr of infection, the media was removed from HaCaTproduct was digested with XhoI and NcoI (sites italicized in primers)
cells cultured in a 75 cm2 flask and the cells washed 3 times in Tris-and inserted between the XhoI and NcoI sites of pET-24d1 (Nova-
buffered saline (pH 7.5). The flask then received 1.5 ml of a lysisgen). Introduction of the restriction sites changed a glycine codon
buffer consisting of 1% Triton X-100 (Sigma) in TBS. The cells wereat residue 2 of the polypeptide to an arginine and a histidine codon
scraped from the flask and the cell suspension transferred to a 1.5at residue 176 to a proline. The primers SpnInv3 (GTCCCT GATGGA
ml plastic screw cap tube. The suspension was incubated at 378CCCTCTG GTACCTC) and SpnInv5 (GCTCTT TACTGA TCAAGG
for 30 min and then subjected to centrifugation (15,000 3 g, 1 min,TAAGGT ACCATC AGCTGACC) were used in an “inside-out” PCR
at room temperature). The soluble material in the supernatant wastechnique to construct an in-frame deletion of the region of the gene
removed to a new tube, and the insoluble material that remainedthat encodes amino acids 177–319. Introduction of the restriction
was resuspended in 50 ml of 63SDS sample buffer (300 mM Tris-sites changed a histidine codon at residue 176 to a proline. The
HCl [pH 6.8]; 60 mM DTT; 12% SDS [weight/vol]; 60% glycerol [vol/PCR product was digested with KpnI (sites italicized in primers) and
vol]; and 0.6% bromophenol blue [weight/vol]). The soluble materialsubjected to ligation. The resulting deletion allele was designated
was diluted 1:6 in SDS sample buffer and soluble and insolublespnD177–319, which was amplified using primers pET24dB (GCGAAA
fractions were subjected to electrophoresis through an 8% SDS-TTAATA CGACTC ACTATA GGGG) and pET24dC (GGCAGC AGC-
PAGE gel and analyzed by a Western blot using a commercial anti-CAA CTAAGC TTCCTT TCGG) and the product inserted between
SLO antiserum (lot #7317011, Golden West Biologicals) developedthe XbaI and HindIII sites of the streptococcol-E. coli shuttle vector
with an anti-rabbit horseradish peroxidase conjugate (Sigma) andpJRS233 using the HindIII restriction site embedded in pET24dC
a chemilumenescent substrate (SuperSignal, Pierce Chemicals). Re-and the unique XbaI site in the pET24d1 vector. The DNA sequence
acting bands were visualized by exposure to film (Biomax MS,of spnD177–319 was confirmed through the use of a commercial auto-
Kodak).mated sequencing method (ABI Prism BigDye) as recommended
by the manufacturer (PE Applied Biosystems) using appropriate
oligonucleotide primers. This analysis revealed that a single nucleo- Preparation and Analysis of Cytoplasm
tide substitution was introduced during amplification that resulted Selective lysis of the eukaryotic cell cytoplasm was conducted by
in changing a tryptophan codon for residue 278 of the polypeptide a modification of the method of Lee and Schneewind (1999) as
to arginine. The wild type spn allele of JRS4 was replaced with follows: Following 3.75 hr of infection of cells in a 75 cm2 flask, cells
spnD177–319 by the method described elsewhere (Ji et al., 1996). The were washed 2 times in PBS and then scraped into suspension in
resulting mutant was designated SPN1 and its chromosomal struc- 1.5 ml of a lysis buffer consisting of Saponin (0.005% weight/vol) in
ture was verified by PCR using primers of the appropriate se- PBS (pH 7.4) supplemented with protease inhibitors (Mini Complete,
quences. Boehringer Mannheim, 1 tablet per 10 ml buffer). The cell suspension
was transferred to a 2 ml screw cap tube that was then incubated
at 378C for 20 min. The cytoplasmic fraction was the supernatantConstruction of a slo Control Strain
In order to ensure that inactivation of slo did not have any deleterious that remained following sequential centrifugation at 15,000 3 g (10
min at RT) followed by 100,000 3 g (60 min at 48C). For lysis byeffects on expression of an adjacent gene on the chromosome that
could be involved in translocation, a control strain was constructed sonication, infected cells from a 75 cm2 flask were scraped into
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